Search

Author/Creator Blair, Elizabeth A

1. Efficacy and safety of dolutegravir–rilpivirine for maintenance of virological suppression in adults with HIV-1: 100-week data from the randomised, open-label, phase 3 SWORD-1 and SWORD-2 studies. Issue 9 (September 2019)

Authors:
Aboud, Michael; Orkin, Chloe; Podzamczer, Daniel; Bogner, Johannes R; Baker, David; Khuong-Josses, Marie-Aude; Parks, David; Angelis, Konstantinos; Kahl, Lesley P; Blair, Elizabeth A; Adkison, Kimberly; Underwood, Mark; Matthews, Jessica E; Wynne, Brian; Vandermeulen, Kati; Gartland, Martin; Smit...
Journal:
Lancet
Issue:
Volume 6:Issue 9(2019)
Page Start:
e576
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Efficacy, safety, and tolerability of dolutegravir-rilpivirine for the maintenance of virological suppression in adults with HIV-1: phase 3, randomised, non-inferiority SWORD-1 and SWORD-2 studies. Issue 10123 (3rd March 2018)

Authors:
Llibre, Josep M; Hung, Chien-Ching; Brinson, Cynthia; Castelli, Francesco; Girard, Pierre-Marie; Kahl, Lesley P; Blair, Elizabeth A; Angelis, Kostas; Wynne, Brian; Vandermeulen, Kati; Underwood, Mark; Smith, Kim; Gartland, Martin; Aboud, Michael
Journal:
Lancet
Issue:
Volume 391:Issue 10123(2018)
Page Start:
839
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search